← Insider buys
RPRX

Royalty Pharma plc · Healthcare

EVP, Research & Investments Marshall Urist sold $239K of Royalty Pharma plc

Sold$238,813
$57.88Price
4,126Shares
−50%Stake

What RPRX did after the filing

Prices for RPRX after this filing aren't in yet.

Traded Mon, Sep 28. Filed Wed, Sep 30, 4:32 PM ET, after the close. Not investment advice.